viral hemorrhagic fever
viral hemorrhagic fever
Explore linked clinical trials. Standard reference: MONDO:001808785 results · Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT07842107 | |
| RVF and Other Emerging Infectious Diseases in East and Central Africa | Bunyaviridae infectious disease, Communicable Diseases, Emerging, Digestive System Diseases, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-10-05 | NCT05139524 | |
| Adaptive Dengue Antiviral Platform Trial | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-09-28 | NCT06551844 | |
| A Trial to Evaluate the Safety, Immunogenicity and the Optimal Dose of MOPEVAC-Las Vaccine Candidate Against Lassa Fever | Arenaviridae infectious disease, Infections, Lassa fever, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07833436 | |
| Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-25 | NCT07706686 | |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health | Filoviridae infectious disease, Infections, Marburg hemorrhagic fever, Mononegavirales infectious disease, RNA Virus Infections, monkey disease, non-human animal disease, non-human primate disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-23 | NCT07425821 | |
| Immune Responses to Dengue and Sepsis | Flaviviridae infectious disease, Flavivirus Infections, Infections, Inflammation, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Sepsis, Systemic Inflammatory Response Syndrome, arbovirus infection, dengue disease, influenza, respiratory system disorder, respiratory tract infectious disorder, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-09-23 | NCT07040202 | |
| A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 3 | 2026-09-22 | NCT06579755 | |
| Phase I Study of VLPDEN-02 Dengue Vaccine in Healthy Adults | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 1 | 2026-09-21 | NCT07831473 | |
| A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health | Ebola hemorrhagic fever, Filoviridae infectious disease, Infections, Mononegavirales infectious disease, RNA Virus Infections, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-21 | NCT07565090 | |
| Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2) | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-09-15 | NCT06917001 | |
| A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-09-15 | NCT06006559 | |
| Retrospective Analysis of the Second Year of Safety Surveillance of the Qdenga® (TAK-003) Vaccine in Private Vaccination Centers, Including a Sub-analysis of Safety in Adults Over 60 Years of Age | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Not stated | 2026-09-10 | NCT07812142 | |
| A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults | Filoviridae infectious disease, Infections, Marburg hemorrhagic fever, Mononegavirales infectious disease, RNA Virus Infections, monkey disease, non-human animal disease, non-human primate disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-10 | NCT06620003 | |
| Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-09-08 | NCT07016321 | |
| Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, vector-borne disease, viral hemorrhagic fever, viral infectious disease, yellow fever | Active, not recruiting | Phase 2 | 2026-09-03 | NCT04942210 | |
| Investigating and Modelling the Natural History of Dengue in Hospitalised Patients to Improve Future Research | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Not stated | 2026-09-02 | NCT07799168 | |
| Smart Analysis and Decision-Making for Emerging Infectious Diseases | Alphavirus infectious disease, COVID-19, Communicable Diseases, Emerging, Coronaviridae Infections, DNA Virus Infections, Disease Attributes, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, avian influenza, bird disease, chikungunya, dengue disease, infectious disease, influenza, lung disorder, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rodent disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease, viral pneumonia | Enrolling by invitation | Not applicable | 2026-08-19 | NCT07678619 | |
| Bridging Economics and Public Trust: A Study of Dengue Vaccine Cost-effectiveness and Acceptance in Thais Visiting Hospital | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Not stated | 2026-08-17 | NCT07759596 | |
| Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, vector-borne disease, viral hemorrhagic fever, viral infectious disease, yellow fever | Recruiting | Not applicable | 2026-08-13 | NCT07636551 | |
| UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF | Bunyaviridae infectious disease, Crimean-Congo hemorrhagic fever, Infections, RNA Virus Infections, arbovirus infection, tick-borne infectious disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-08-07 | NCT06860334 | |
| Gut Leakage' in Dengue | Ascites, Digestive System Diseases, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, arbovirus infection, dengue disease, dengue shock syndrome, digestive system disorder, intestinal disorder, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-08-06 | NCT07602920 | |
| Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE) | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-07-29 | NCT04597437 | |
| A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 3 | 2026-07-17 | NCT07047521 | |
| Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. | Alphavirus infectious disease, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Not yet recruiting | Phase 3 | 2026-07-16 | NCT06973772 |